- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Oncotarget. 6.2015; Nr. 31, S. 31877-31888, doi: 10.18632/oncotarget.5047
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2015
- Urheber
-
Weber, Helga
Leal, Pamela
Stein, Stefan
Kunkel, Hana
García, Patricia
Bizama, Carolina
Espinoza, Jaime A.
Riquelme, Ismael
Nervi, Bruno
Araya, Juan C.
Grez, Manuel
Roa, Juan C.
- URN
-
urn:nbn:de:hebis:30:3-412871
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weber, Helga
- Leal, Pamela
- Stein, Stefan
- Kunkel, Hana
- García, Patricia
- Bizama, Carolina
- Espinoza, Jaime A.
- Riquelme, Ismael
- Nervi, Bruno
- Araya, Juan C.
- Grez, Manuel
- Roa, Juan C.
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2015
Ähnliche Objekte (12)
Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts
Target of rapamycin signaling regulates high mobility group protein association to chromatin, which functions to suppress necrotic cell death
Brüssel, Wye-Vortrag, 2000
England. Wales, Wye Tal
Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo
Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts
Aortenklappenersatz mit Allografts und Xenografts
Xenografts in septic vascular surgery
Therapeutisches Drug Monitoring bei Rapamycin
Allgemeine Korrespondenz: Aspen Institut.- Wye Papers
Wye Valley Studios mit Harry Rosenthal
Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts
Target of rapamycin signaling regulates high mobility group protein association to chromatin, which functions to suppress necrotic cell death
Brüssel, Wye-Vortrag, 2000
England. Wales, Wye Tal
Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo
Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts
Aortenklappenersatz mit Allografts und Xenografts
Xenografts in septic vascular surgery
Therapeutisches Drug Monitoring bei Rapamycin
Allgemeine Korrespondenz: Aspen Institut.- Wye Papers
Wye Valley Studios mit Harry Rosenthal
Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts
Target of rapamycin signaling regulates high mobility group protein association to chromatin, which functions to suppress necrotic cell death
Brüssel, Wye-Vortrag, 2000
England. Wales, Wye Tal
Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo
Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts
Aortenklappenersatz mit Allografts und Xenografts
Xenografts in septic vascular surgery
Therapeutisches Drug Monitoring bei Rapamycin
Allgemeine Korrespondenz: Aspen Institut.- Wye Papers